A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)

计划入组 185 人 · 首次发布于 2016 年 4 月 5 日

GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

计划入组 40 人 · 首次发布于 2026 年 1 月 5 日

CYTALUX™for the Intraoperative Imaging of Prostate Cancer

计划入组 9 人 · 首次发布于 2024 年 5 月 30 日

ENKASTIM™

Covax-19™

The Institute For Cancer Research

United States

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

United States

JAPANESE FOUNDATION FOR CANCER RESEARCH

Japan

20/20 BioLabs Charts Path Toward Medicare Reimbursement for OneTest™ MCED Blood Test, Reports Strong Q2 Revenue Growth

20/20 BioLabs Partners with ROKIT Healthcare to Integrate CKD Prediction Technology into Longevity Testing Platform

Health Canada Approves Fruquintinib (Fruzaqla) for Metastatic Colorectal Cancer